Occupational outcomes of people with multiple sclerosis: a scoping review.
EPIDEMIOLOGY
Health economics
Multiple sclerosis
Neurology
OCCUPATIONAL & INDUSTRIAL MEDICINE
PUBLIC HEALTH
Journal
BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874
Informations de publication
Date de publication:
01 07 2022
01 07 2022
Historique:
entrez:
1
7
2022
pubmed:
2
7
2022
medline:
8
7
2022
Statut:
epublish
Résumé
To update the knowledge on the occupational outcomes associated with multiple sclerosis (MS), systematically examine the extent, scope and nature of the pre-existing literature and identify research gaps in the existing literature. Scoping review. A comprehensive database search of PubMed/MEDLINE, Scopus, SciVerse ScienceDirect and Web of Science was performed. There were no time limits. We included any peer-reviewed original article reporting the occupational outcomes of people with MS between the ages of 18 and 65 years. We excluded those off-topic and with insufficient information. This review was conducted following the Joanna Briggs Institute recommendations and the Preferred Reporting Items for Systematic Reviews and Meta-Analyses for scoping review checklist. Screening, reading of full-texts and data extraction was performed in a standardised way by expert reviewers from 14 July 2021 to 31 October 2021. We provided a narrative synthesis and an overview of findings. The initial systematic search yielded 104 228 results. After removing duplicates and applying the exclusion criteria, 403 articles were included in the review. In total, the studies evaluated 492 062 subjects with MS. One hundred fifty-four (38.2%) articles were published in the last 5 years, mostly from Europe and North America (50.9% and 33.0%, respectively). Concerning the occupational outcomes, studies mostly addressed unemployment (311, 77.2%), early retirement (120, 29.8%), disability pension (117, 29.0%), sick leave (77, 19.1%), the indirect cost of MS (74, 18.4%) and work characteristics (57, 14.1%). The results were categorised into seven subtopics: 'Changes in work and occupational status due to MS', 'work-related socio-economic consequences of MS', 'risk factors for unfavourable occupational outcomes', 'reported barriers to employment', 'reported job accommodations and vocational rehabilitation strategies', 'job satisfaction, stigma, and disclosing the diagnosis in the workplace' and 'rating clinical scales'. There are several issues that deserve further in-depth study by the scientific community in order to improve the occupational outcomes of people with MS.
Identifiants
pubmed: 35777874
pii: bmjopen-2021-058948
doi: 10.1136/bmjopen-2021-058948
pmc: PMC9252209
doi:
Types de publication
Journal Article
Systematic Review
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e058948Informations de copyright
© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
Déclaration de conflit d'intérêts
Competing interests: None declared.
Références
Mult Scler. 2017 Jul;23(8):1137-1147
pubmed: 27758955
Pharmacoeconomics. 2009;27(8):681-91
pubmed: 19712010
Int J Environ Res Public Health. 2020 Aug 24;17(17):
pubmed: 32846878
Mult Scler. 2021 Jul;27(8):1250-1261
pubmed: 32880529
Disabil Rehabil. 2012;34(24):2031-8
pubmed: 22468710
Mult Scler. 2012 Jun;18(6):862-70
pubmed: 22041093
Arch Phys Med Rehabil. 2018 Feb;99(2):272-280
pubmed: 28928026
Mult Scler. 2021 Nov;27(13):2093-2102
pubmed: 33591218
Mult Scler. 2013 Nov;19(13):1792-9
pubmed: 23635910
Nat Rev Dis Primers. 2018 Nov 8;4(1):43
pubmed: 30410033
Disabil Rehabil. 2014;36(8):635-41
pubmed: 23786346
Work. 2020;67(1):81-94
pubmed: 32986637
Mult Scler. 2014 Jan;20(1):116-9
pubmed: 23842211
Can J Neurol Sci. 2003 May;30(2):137-42
pubmed: 12774953
Eur J Neurol. 2019 Jan;26(1):27-40
pubmed: 30300457
Neurology. 2006 Jun 13;66(11):1696-702
pubmed: 16769943
Mult Scler Relat Disord. 2020 Jul;42:102077
pubmed: 32353754
Mult Scler Relat Disord. 2020 Nov;46:102519
pubmed: 32977076
Lancet Neurol. 2009 Mar;8(3):254-60
pubmed: 19201654
J Neurol. 2008 Sep;255(9):1354-60
pubmed: 18677639
Work. 2014;47(4):509-20
pubmed: 23531588
Curr Med Res Opin. 2011 Jan;27(1):179-88
pubmed: 21138336
Eur J Health Econ. 2018 Apr;19(3):435-446
pubmed: 28488184
Mult Scler Relat Disord. 2020 Sep;44:102247
pubmed: 32554286
Mult Scler. 2007 Nov;13(9):1183-9
pubmed: 17623726
Nurs Res. 1991 Mar-Apr;40(2):107-12
pubmed: 2003069
Int J Environ Res Public Health. 2016 Oct 31;13(11):
pubmed: 27809265
J Med Econ. 2013;16(5):639-47
pubmed: 23425293
Mult Scler. 2017 Aug;23(2_suppl):155-165
pubmed: 28643590
Mult Scler Relat Disord. 2020 Jun;41:102046
pubmed: 32179482
Eur J Neurol. 2010 Nov;17(11):1346-51
pubmed: 20402759
Int J Evid Based Healthc. 2015 Sep;13(3):141-6
pubmed: 26134548
Mult Scler. 2021 Jun;27(7):1125-1135
pubmed: 32757907
BMC Public Health. 2019 May 20;19(1):609
pubmed: 31109317
Ann Readapt Med Phys. 2008 Jun;51(5):386-93
pubmed: 18565608
J Neurol Sci. 2006 May 15;244(1-2):127-31
pubmed: 16527310
BMJ Open. 2020 Nov 30;10(11):e041249
pubmed: 33257490
Arch Phys Med Rehabil. 2021 Aug;102(8):1556-1561
pubmed: 33684369
Mult Scler Relat Disord. 2015 Jul;4(4):315-9
pubmed: 26195049
J Neurol. 2015 Nov;262(11):2425-32
pubmed: 26205635
Value Health. 2012 Dec;15(8):1029-35
pubmed: 23244804
Acta Neurol Scand. 2015 Oct;132(4):226-34
pubmed: 25690402
Mult Scler Relat Disord. 2015 Sep;4(5):409-413
pubmed: 26346789
J Neurol Sci. 2015 Oct 15;357(1-2):209-14
pubmed: 26238165
Mult Scler. 2017 Aug;23(2_suppl):104-116
pubmed: 28643600
Eur Neuropsychopharmacol. 2012 Jan;22(1):36-43
pubmed: 21669514
Ann Intern Med. 2018 Oct 2;169(7):467-473
pubmed: 30178033
Eur J Neurol. 2019 Dec;26(12):1447-1454
pubmed: 31183915
Rev Neurol (Paris). 2016 Jan;172(1):3-13
pubmed: 26718593
J Health Psychol. 2019 Jan;24(1):38-51
pubmed: 28810436
Int J Rehabil Res. 2004 Mar;27(1):37-44
pubmed: 15097168
Mult Scler. 2019 Jun;25(7):994-1004
pubmed: 29911469
Int Arch Occup Environ Health. 2006 Nov;80(2):160-70
pubmed: 16710710
Mult Scler Relat Disord. 2021 May;50:102860
pubmed: 33647591
Rev Neurol (Paris). 2015 Nov;171(11):782-6
pubmed: 26343923
J Neurol. 2011 Feb;258(2):244-9
pubmed: 20835872
Disabil Rehabil. 2016;38(10):936-44
pubmed: 26213244
J Neuroimmunol. 2021 Sep 15;358:577650
pubmed: 34274720
PLoS One. 2015 Dec 22;10(12):e0145435
pubmed: 26695832
Acta Neurol Scand. 2021 Jun;143(6):587-601
pubmed: 33748960
Health Qual Life Outcomes. 2018 Jun 1;16(1):113
pubmed: 29859113
Mult Scler. 2013 Oct;19(12):1640-6
pubmed: 23652216
Eur J Health Econ. 2006 Sep;7 Suppl 2:S96-104
pubmed: 17310341
Mult Scler. 2017 Aug;23(2_suppl):192-203
pubmed: 28643596
Mult Scler. 2014 Jun;20(7):871-6
pubmed: 24263383
Mult Scler Relat Disord. 2020 Nov;46:102487
pubmed: 32916511
PLoS One. 2014 Jul 23;9(7):e103317
pubmed: 25054972
NeuroRehabilitation. 2015;37(3):425-36
pubmed: 26484524
Mult Scler. 2015 Feb;21(2):225-34
pubmed: 25070678
Mult Scler. 2019 Mar;25(3):419-426
pubmed: 29363395
Int J MS Care. 2019 Sep-Oct;21(5):214-225
pubmed: 31680783
J Neurol Neurosurg Psychiatry. 2006 Aug;77(8):918-26
pubmed: 16690691
Arq Neuropsiquiatr. 2019 May 01;77(5):341-345
pubmed: 31188998
Work. 2003;21(1):69-76
pubmed: 12897392